These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38515943)

  • 41. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.
    Adam R; De Gramont A; Figueras J; Guthrie A; Kokudo N; Kunstlinger F; Loyer E; Poston G; Rougier P; Rubbia-Brandt L; Sobrero A; Tabernero J; Teh C; Van Cutsem E;
    Oncologist; 2012; 17(10):1225-39. PubMed ID: 22962059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Choice of surgical strategy for colorectal liver metastases depending on clinical and pathological response to neoadjuvant chemo- and targeted therapy].
    Jakab F
    Orv Hetil; 2010 Nov; 151(47):1956-60. PubMed ID: 21071308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy].
    Brouquet A; Benoist S
    Bull Cancer; 2011 Jan; 98(1):11-8. PubMed ID: 21300602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
    Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
    Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Up front hepatectomy for metastatic rectal carcinoma - reversed, liver first approach. Early experience with 15 patients.
    Straka M; Skrovina M; Soumarova R; Kotasek R; Burda L; Vojtek C
    Neoplasma; 2014; 61(4):447-52. PubMed ID: 25027742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.
    Bolhuis K; Bond MJG; Van Amerongen MJ; Komurcu A; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik TM; Hermans JJ; De Jong KP; Kazemier G; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; May AM; Punt CJA; Swijnenburg RJ;
    Eur J Cancer; 2023 Apr; 183():49-59. PubMed ID: 36801606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value and prognostic factors of repeat hepatectomy for recurrent colorectal liver metastasis.
    Zhou JM; Wang L; Mao AR
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):570-576. PubMed ID: 36858891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer.
    Diehl TM; Abbott DE
    Curr Treat Options Oncol; 2021 Jul; 22(9):82. PubMed ID: 34224023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
    Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
    World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities.
    Karaoğlan BB; Öz DK; Araz MS; Akyol C; Utkan G
    Curr Oncol Rep; 2024 Jul; 26(7):791-803. PubMed ID: 38776011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in neoadjuvant therapy for colorectal cancer with liver metastases.
    Pozzo C; Barone C; Kemeny NE
    Cancer Treat Rev; 2008 Jun; 34(4):293-301. PubMed ID: 18291590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient selection for the surgical treatment of resectable colorectal liver metastases.
    Araujo RL; Riechelmann RP; Fong Y
    J Surg Oncol; 2017 Feb; 115(2):213-220. PubMed ID: 27778357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rethinking of the conversion therapy in colorectal cancer patients with liver metastasis].
    Xu D; Xing BC
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):81-85. PubMed ID: 30862134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.
    Schwarz RE; Berlin JD; Lenz HJ; Nordlinger B; Rubbia-Brandt L; Choti MA
    HPB (Oxford); 2013 Feb; 15(2):106-15. PubMed ID: 23297721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro adjuvant chemotherapy].
    Lordick F; Knödler M; Hacker U; Bartels M
    Chirurg; 2014 Jan; 85(1):11-6. PubMed ID: 24292192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neoadjuvant chemotherapy as a treatment strategy for multiple bilobar liver metastases from colorectal carcinoma].
    Suzuki S; Sakaguchi T; Nakamura T; Nakamura S; Konno H
    Nihon Geka Gakkai Zasshi; 2006 May; 107(3):128-32. PubMed ID: 16734269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study.
    Han L; Xue J; Wu X; Liang G; Wu Y; Guo F; Gao S; Sun G
    Ann Palliat Med; 2022 Feb; 11(2):717-729. PubMed ID: 35249349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
    Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The developing clinical problem of chemotherapy-induced hepatic injury.
    Pilgrim CH; Thomson BN; Banting S; Phillips WA; Michael M
    ANZ J Surg; 2012; 82(1-2):23-9. PubMed ID: 22507491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.